Multiple Sclerosis (CCSVII)
Steps Involved in IVF:
Procedure Description
Chronic Cerebrospinal Venous Insufficiency (CCSVI) is a condition hypothesized to play a role in Multiple Sclerosis (MS), a neurological disease affecting the brain and spinal cord. The theory suggests that narrowed veins in the neck or chest impede the normal drainage of blood from the brain and spinal cord. This venous blockage may lead to insufficient blood outflow, increasing pressure and contributing to the inflammation and degeneration seen in MS patients. Treatment of CCSVI, sometimes referred to as "liberation therapy," aims to open these veins, thereby improving blood flow and potentially alleviating some symptoms of MS.
The CCSVI treatment usually involves a procedure known as balloon angioplasty, which is similar to the angioplasty performed for blocked arteries in heart disease. In this procedure, a balloon is inserted into the narrowed vein using a catheter and is inflated to widen the vein, allowing for better blood flow. In some cases, a stent (a small mesh tube) may be inserted to keep the vein open. This minimally invasive approach is typically performed under local anesthesia, and it aims to restore proper venous circulation from the brain and spinal cord.
While the connection between CCSVI and MS is still under study, some patients have reported improvements in symptoms such as fatigue, cognitive difficulties, and motor control after undergoing the procedure. It’s important to note that CCSVI treatment is not currently a standard therapy for MS and is still considered experimental by many medical experts. Nevertheless, interest in the procedure is growing as more research emerges on its potential benefits.
Procedure Duration
The CCSVI procedure, or venoplasty, is usually performed as an outpatient procedure, often lasting between 1 to 2 hours. Initially, a detailed assessment of the patient’s vascular system is performed using imaging techniques like Doppler ultrasound, Magnetic Resonance Venography (MRV), or catheter venography to identify any narrowed or blocked veins. This diagnostic phase helps the medical team determine the extent of the venous insufficiency and plan the appropriate intervention.
During the procedure, the patient lies down on an operating table, and a catheter is inserted into a vein, typically in the groin area. Using real-time imaging guidance, the catheter is threaded up to the narrowed area of the veins in the neck or chest. Once in place, the balloon angioplasty is performed, and in some instances, a stent is placed to maintain the opening. The procedure itself is relatively quick, and most patients can leave the hospital the same day or the next day, depending on their recovery and the healthcare provider’s protocol.
Recovery time is generally short, with most patients resuming normal activities within a few days. Patients may experience some soreness at the catheter insertion site and are advised to avoid strenuous activities for about a week. Follow-up assessments are often scheduled to monitor the effects of the procedure, and patients are encouraged to keep track of any changes in their MS symptoms.
Benefits
- Potential Symptom Relief: Some patients have reported improvements in fatigue, muscle weakness, cognitive functions, and overall quality of life following the CCSVI procedure.
- Minimally Invasive: The angioplasty technique used to treat CCSVI is less invasive than surgical alternatives, allowing for quicker recovery.
- Outpatient Procedure: Typically performed on an outpatient basis, reducing the need for extended hospital stays.
- Rapid Recovery Time: Most patients can return to normal activities within a few days, making it convenient for medical tourists.
- Growing Research Interest: With ongoing research, there is potential for further understanding of CCSVI’s role in MS and refinement of the treatment technique.
Potential Destinations
- Poland
Poland is becoming a notable destination for CCSVI treatment due to its high standards of healthcare, affordable costs, and experienced vascular surgeons. The country’s advanced medical facilities and focus on patient-centered care attract many international patients seeking venous interventions for MS.
- India
Known for its medical tourism industry, India offers a range of treatments for neurological conditions, including CCSVI. Patients benefit from highly skilled doctors, advanced technology, and affordable treatment options. The country’s vast healthcare infrastructure and extensive experience in vascular treatments make it an attractive choice.
- Mexico
Mexico is gaining popularity for CCSVI treatments, particularly among North American patients. With state-of-the-art medical facilities and highly trained professionals, Mexico provides cost-effective options for venoplasty and offers shorter travel distances for patients from the U.S. and Canada.
- Italy
As the birthplace of the CCSVI theory, Italy remains at the forefront of research and treatment for this condition. Many Italian clinics offer advanced diagnostics and personalized treatment plans. Patients visiting Italy benefit from a deep understanding of MS and CCSVI by local healthcare practitioners.
- Turkey
Turkey has become a global hub for medical tourism, offering quality healthcare at competitive prices. The country’s medical centers are equipped with modern technology and well-trained vascular specialists. Its strategic location, between Europe and Asia, makes it a convenient destination for patients from multiple regions.
Risks & Considerations
- Procedural Complications: As with any intervention involving the veins, there is a risk of bleeding, infection, and damage to the blood vessels during the procedure.
- Stent-Related Issues: In cases where a stent is used, there is a potential risk of migration, thrombosis, or restenosis (re-narrowing of the vein).
- Lack of Standardization: The CCSVI procedure is not yet widely accepted as a standard treatment for MS, and variations in the technique may exist among different providers.
- Uncertain Long-Term Outcomes: Since the procedure is relatively new and still under investigation, the long-term benefits and potential side effects are not fully understood.
- Mixed Efficacy: The results of CCSVI treatment have been mixed, with some patients experiencing improvements in symptoms while others see little to no benefit, underscoring the need for further research and patient-specific assessments.
How to Choose the Right Doctor and Hospital
Selecting a qualified doctor and reputable hospital is crucial for those considering CCSVI treatment. Start by researching the provider’s experience with venoplasty and specifically with CCSVI. Look for a practitioner who has a solid background in interventional radiology or vascular surgery and is experienced in diagnosing and treating CCSVI. Additionally, ensure the facility has advanced imaging capabilities for proper assessment and planning of the procedure.
It's also essential to evaluate the hospital’s overall reputation, accreditation status, and patient care standards. Seek out hospitals known for their focus on neurology and vascular health, as these centers are more likely to have specialized teams that understand the complexities of MS and its potential link to CCSVI. Consulting patient testimonials, success rates, and post-procedure care options can further help in making an informed decision.
To receive a free quote for this procedure please click on the link: https://www.medicaltourism.com/get-a-quote
Patients are advised to seek hospitals that are accredited by Global Healthcare and only work with medical tourism facilitators who are certified by Global Healthcare Accreditation or who have undergone certification from the Certified Medical Travel Professionals (CMTP). This ensures that the highest standards in the industry are met. GHA accredits the top hospitals in the world. These are the best hospitals in the world for quality and providing the best patient experience. Click the link to check out hospitals accredited by the Global Healthcare Accreditation: https://www.globalhealthcareaccreditation.com
Frequently Asked Questions
What actually happens during hyperstimulation of the ovaries?
The patient will take injectable FSH (follicle stimulating hormone) for eight to eleven days, depending on how long the follicles take to mature. This hormone is produced naturally in a woman’s body causing one egg to develop per cycle. Taking the injectable FSH causes several follicles to develop at once, at approximately the same rate. The development is monitored with vaginal ultrasounds and following the patient’s levels of estradiol and progesterone. FSH brand names include Repronex, Follistim, Menopur, Gonal-F and Bravelle. The patient injects herself daily.
What happens during egg retrieval?
When the follicles have developed enough to be harvested, the patient attends an appointment where she is anesthetized and prepared for the procedure. Next, the doctor uses an ultrasound probe to guide a needle through the vaginal wall and into the follicle of the ovary. The thin needle draws the follicle fluid, which is then examined by an embryologist to find the eggs. The whole process takes about 20 minutes.
What happens to the eggs?
In the next step, the harvested eggs are then fertilized. If the sperm from the potential father, or in some cases, anonymous donor, has normal functionality, the eggs and sperm are placed together in a dish with a nutrient fluid, then incubated overnight to fertilize normally. If the sperm functionality is suboptimal, an embryologist uses Intracytoplasmic Sperm Injection to inject a single sperm into a single egg with an extremely precise glass needle. Once fertilization is complete, the embryos are assessed and prepared to be transferred to the patient’s uterus.
How are the embryos transferred back to the uterus?
The doctor and the patient will discuss the number of embryos to be transferred. The number of successfully fertilized eggs usually determines the number of eggs to be placed in the uterus. Embryos are transferred to the uterus with transabdominal ultrasound guidance. This process does not require anesthesia, but it can cause minor cervical or uterine discomfort. Following transfer, the patient is advised to take at least one days bed rest and two or three additional days of rest, then 10 to 12 days later, two pregnancy tests are scheduled to confirm success. Once two positive tests are completed, an obstetrical ultrasound is ordered to show the sac, fetal pole, yolk sac and fetal heart rate.
Embryoscope©
Built into this technology there is a microscope with a powerful camera that allows the uninterrupted monitoring of the embryo during its first hours of life. In this way, we can keep a close eye on the embryo, from the moment when the oocyte is inseminated and begins to divide into smaller and smaller cells, until it can be transferred to the uterus.
Orthopedics Stem Cell
Knee
Research on mesenchymal stem cells regenerative properties in knee osteoarthritis. In these studies, researchers suggest that Stem Cell Therapy has the potential to regenerate lost cartilage, stop and reverse cartilage degeneration, provide pain relief, and improve patient mobility.
Shoulder
Stem Cell Therapy as an Alternative to Rotator Cuff & Shoulder Replacement Surgery. Stem cell therapy may offer an excellent alternative for patients looking to avoid shoulder joint replacement surgery, as well as many other surgical treatments for shoulder pain.
Ankle
If you suffer from chronic or acute ankle pain or instability due to arthritis, cartilage loss, ligament strain or tear, or tendon damage, then you may benefit from non-surgical stem cell treatments or stem cell-enhanced surgery.
Back Pain
Patients now have a minimally invasive option. Stem cell therapy for back pain and disc herniations can potentially repair the damaged disc or facet joint, restore function, rehydrate the disc, and ultimately alleviate chronic pain.
Anti-Aging Stem Cell
Hair Loss
Stem cell therapy and PRP therapy have been shown to be most effective for: Those in the early stages of hair loss, patients who are not viable candidates for surgery and women who prefer to avoid hair surgery.
Facial Anti-Aging
Aesthetic Anti-Aging. The Aesthetic Stem Cell Localized Treatment is a non-surgical minimally invasive procedure to enhance the appearance of aging skin and hair restoration. This all-natural technique combines dermal injections of bone marrow or adipose tissue derived stem cells and growth factors.
Fertility Stem Cell
Endometrial PRP
The stem cells used for treatment of a thin endometrium include mesenchymal stem cells. In addition, successful repair of the endometrium in pregnancy with stem cells has been reported previously.
Low Ovarian Reserve (PRP)
The treatment uses PRP (Platelet-Rich-Plasma), which with stem cell therapy is the novel therapeutic approach for restoring the quality of the ovarian reserve.Your PRP will contain a physiologic balance of platelets, growth factors and white blood cells tailored specifically for you.
Punta Mita Hospital
Mexico
Punta Mita Hospital - Genesis Cell
Mexico
